The Invader® HCV genotyping technology platform enables clinical laboratories to develop assays that identify all six genotypes of the HCV virus. Use of the Invader platform in manual assay setups provides results faster than other commercially available technologies. The high-throughput and ease-of-use advantages of the company’s proprietary Invader platform enables laboratories to automate the HCV genotyping process easily, reducing hands-on time, while decreasing the time to result.

Third Wave Technologies Inc
(888) 898-2357;